Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Paediatrics and International Child Health
|
June 13, 2022
Ulcerative colitis in patients with sickle cell disease: a rare but important co-morbidity
Angela E Rankine-Mullings
The Cochrane Database of Systematic Reviews
|
October 11, 2017
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease
Angela E Rankine-Mullings, Shirley Owusu-Ofori
The Cochrane Database of Systematic Reviews
|
March 16, 2021
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease
Angela E Rankine-Mullings, Shirley Owusu-Ofori
The Cochrane Database of Systematic Reviews
|
September 1, 2022
Hydroxyurea (hydroxycarbamide) for sickle cell disease
Angela E Rankine-Mullings, Sarah J Nevitt
Pediatric Blood & Cancer
|
December 29, 2022
Early splenomegaly and septicaemia in homozygous sickle cell disease: A birth cohort study
Angela E Rankine-Mullings, T M Logan, M Asnani, et al.
Journal of Medical Case Reports
|
January 15, 2019
The additional genetic diagnosis of homozygous sickle cell disease in a patient with Waardenburg-Shah syndrome: a case report
Angela E Rankine-Mullings, Graham Serjeant, Zachary Ramsay, et al.
Clinics and Practice
|
May 22, 2014
Gangrene of the digits of the right lower limb in a patient with homozygous sickle cell disease and ulcerative colitis
Angela E Rankine-Mullings, Jennifer M Knight-Madden, Marvin Reid, et al.
British Journal of Haematology
|
March 6, 2018
Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition
Angela E Rankine-Mullings, Nadine Morrison-Levy, Deanne Soares, et al.
JMIR Research Protocols
|
September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia
Angela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
Blood Advances
|
September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Alexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Paediatrics and International Child Health
|
June 13, 2022
Ulcerative colitis in patients with sickle cell disease: a rare but important co-morbidity
Angela E Rankine-Mullings
The Cochrane Database of Systematic Reviews
|
October 11, 2017
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease
Angela E Rankine-Mullings, Shirley Owusu-Ofori
The Cochrane Database of Systematic Reviews
|
March 16, 2021
Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease
Angela E Rankine-Mullings, Shirley Owusu-Ofori
The Cochrane Database of Systematic Reviews
|
September 1, 2022
Hydroxyurea (hydroxycarbamide) for sickle cell disease
Angela E Rankine-Mullings, Sarah J Nevitt
Pediatric Blood & Cancer
|
December 29, 2022
Early splenomegaly and septicaemia in homozygous sickle cell disease: A birth cohort study
Angela E Rankine-Mullings, T M Logan, M Asnani, et al.
Journal of Medical Case Reports
|
January 15, 2019
The additional genetic diagnosis of homozygous sickle cell disease in a patient with Waardenburg-Shah syndrome: a case report
Angela E Rankine-Mullings, Graham Serjeant, Zachary Ramsay, et al.
Clinics and Practice
|
May 22, 2014
Gangrene of the digits of the right lower limb in a patient with homozygous sickle cell disease and ulcerative colitis
Angela E Rankine-Mullings, Jennifer M Knight-Madden, Marvin Reid, et al.
British Journal of Haematology
|
March 6, 2018
Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition
Angela E Rankine-Mullings, Nadine Morrison-Levy, Deanne Soares, et al.
JMIR Research Protocols
|
September 14, 2016
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia
Angela E Rankine-Mullings, Courtney R Little, Marvin E Reid, et al.
Blood Advances
|
September 30, 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Alexandra Power-Hays, Kathryn E McElhinney, Thomas N Williams, et al.
Page
of 1